Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Commercialization symbols : TAK save search
Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN)
Published: 2021-11-17 (Crawled : 15:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: -0.5%
H: 0.2%
C: 0.07%
DNLI | $15.67 -2.73% 190K
|
Health Technology
|
| O: -0.95%
H: 0.0%
C: 0.0%
commercialization
Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals
Published: 2021-09-30 (Crawled : 09:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: 0.74%
H: 0.73%
C: -0.3%
therapy collaboration syndros commercialization
Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan
Published: 2021-09-21 (Crawled : 13:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: 1.35%
H: 0.58%
C: 0.06%
MIRM | $24.1 -1.31% 46K
|
Health Technology
|
| O: 5.09%
H: 2.63%
C: 0.53%
disease liver disease liver license commercialization rare
Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
Published: 2021-03-03 (Crawled : 10:48) - investors.ovidrx.com
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: 2.03%
H: 1.14%
C: 0.68%
OVID | $3.16 -1.25% 14K
|
Health Technology
|
| O: 58.45%
H: 1.28%
C: -13.86%
treatment commercialization children syndros dravet syndrome
KSQ Therapeutics and Takeda Enter Broad Strategic Collaboration to Research, Develop and Commercialize Novel Immuno-Oncology Therapies
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: -0.93%
H: 0.11%
C: -0.22%
collaboration research therapy commercialization
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
WIMI | $1.05 44.75% 13M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.